【英語タイトル】Global Ubiquinone Market Size study & Forecast, by Production method (Microbial Fermentation and Chemical Synthesis), by Application (Dietary supplements, Pharmaceuticals and Cosmetics) and Regional Analysis, 2022-2029
	・商品コード：BZW23FE0066 ・発行会社（調査会社）：Bizwit Research & Consulting ・発行日：2023年2月8日 ・ページ数：約200 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後3営業日） ・調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東 ・産業分野：化学

Global Ubiquinone Market is valued at approximately USD 496.33 million in 2021 and is anticipated to grow with a healthy growth rate of more than 4.8% over the forecast period 2022-2029. Ubiquinone or Coenzyme Q10 (CoQ10), is a naturally occurring vitamin-like molecule found in plants, animals, and the human body. It can be discovered in the heart, kidney, liver, and pancreas of a human. Additionally, ubiquinone is produced industrially using two different processes, including chemical synthesis and microbial fermentation. Additionally, it is frequently used to treat illnesses including Huntington’s disease, breast cancer, gum infections, and others as well as problems of the heart like congestive heart failure. It is frequently used in the pharmaceutical and nutraceutical industries to make tablets, supplements, and capsules. The rising pharmaceuticals and nutraceuticals industries and growing Geriatric Population as well as strategic initiatives from leading market players are key factors accelerating the market growth.

The rising growth of the pharmaceuticals & nutraceuticals industries is contributing to the growth of the Global Ubiquinone Market. For instance, according to Statista – as of 2022, the revenue in the global pharmaceuticals market is estimated at USD 1,109 million, and the revenue is projected to show an annual growth rate (CAGR 2022-2027) of 5.23%, to reach a market volume of USD 1,431 million by 2027. Moreover, as per Statista – in 2019, the nutraceuticals market was valued at USD 83.76 million, and the market is projected to grow to USD 133.4 million by 2025. Also, rising prevalence of chronic disorders and increasing usage in cognitive disease treatment would create a lucrative growth prospectus for the market over the forecast period. However, stringent government regulations towards ubiquinone usage stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Ubiquinone Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the presence of leading market players and increasing consumption of dietary supplements in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and growing pharmaceutical sector in the region.

Major market players included in this report are:
Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd.
Kaneka Corporation
Kyowa Hakko Bio Co., Ltd.
Oriental Yeast Co., Ltd.
Shandong Octagon Chemicals Limited
Shenzhou Biology & Technology Co., Ltd.
Sinoway Industrial Co., Ltd.
Spectrum Chemical Manufacturing Corp.
Tokiwa Phytochemical Co., Ltd.
Xiamen Kingdomway Group Company

Recent Developments in the Market:
 In August 2022, KaraMD announced the launch of CoQ10 Plus, a natural supplement intended to support heart health and the function of muscles. This new supplement is formulated to reduce oxidative stress, improve cellular energy, and support heart health.

Global Ubiquinone Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Production Method, Application, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Production Method
Microbial Fermentation
Chemical Synthesis

By Application
Dietary supplements
Pharmaceuticals
Cosmetics

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World